Your Position: News > Company News > Biouhan Made International Debut at Medica21

Biouhan Made International Debut at Medica21

From Nov.15th to Nov.18 th, Biouhan exhibited at Medica21, the world's largest medical trade fair that runs yearly in Duesseldorf, Germany. This is Biouhan's first time ever showing internationally in the company’s history, despite that our COVID-19 testing products have been distributed to over 60 countries since the Pandemic.

At Medica stand 9D43, Biouhan showcased our full line of COVID-19 test kits and supporting instruments, from Antigen Home Test that is quite a hit in Australia, Antigen Rapid Test Colloidal Gold to IgM IgG Antibody Test with FDA EUA. We also proudly launched two models as the first of its kind each worldwide that give ideal quantitative results when used with our BOH-180 Analyzer: POC Antigen Quantitative Test and POC Antibody Quantitative Test.

More than 100 incumbent distributors and zealous visitors stopped by the Biouhan stand over the four days of the show, reviewed our business past and discussed our cooperation for the year 2022 and beyond. Many visitors even tested Biouhan kits and instruments on themselves, got convinced of the product performance and proposed dealership or orders on the spot.

Having beaten all odds travelling to and back from Duesseldorf in the year of Pandemic, Biouhan's international sales team took home abundant results. This historic show at Medica21 has set an important milestone in Biouhan's steadfast pursuit of globalization.